所有图片（1/1）

CD300c/LMIR2 His Tag Protein, Human

CD300c antigenCMRF35 antigen,CD300c molecule,CD300c,CLM6,CLM-6,CMRF35 leukocyte immunoglobulin-like receptor,CMRF35,CMRF-35,CMRF35A leukocyte immunoglobulin-like receptor,CMRF-35A,CMRF35ACMRF35A1,CMRF35CMRF35-A1,CMRF35-like molecule 6,IGSF16,IgSF16,IGSF16CD300 antigen-like family member C,Immunoglobulin superfamily member 16,LIR

Datasheet COA

价格￥1,180.00 （供应商现货： 3-5个工作日）

货号 UA010870

规格

25μg100μg500μg

数量

产品介绍

产品介绍评论(0)

产品规格

物种

Human
分子别名

CD300c antigenCMRF35 antigen; CD300c molecule; CD300c; CLM6; CLM-6; CMRF35 leukocyte immunoglobulin-like receptor; CMRF35; CMRF-35; CMRF35A leukocyte immunoglobulin-like receptor; CMRF-35A; CMRF35ACMRF35A1; CMRF35CMRF35-A1; CMRF35-like molecule 6; IGSF16 ; IgSF16; IGSF16CD300 antigen-like family member C; Immunoglobulin superfamily member 16; LIR
Accession

Q08708
表达序列

Met29-Arg183, with C-terminal His
表达宿主

HEK293
分子量

30-45kDa (Reducing)
纯度

＞95% by SDS-PAGE
内毒素含量

<0.1EU/μg
标记

Unconjugated
标签

His Tag
性状

Lyophilized Powder
缓冲体系

PBS, pH7.4.
溶解方法

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
储存条件

· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
文献引用

1.Clark, G.J. et al. (2001) Tissue Antigens 57:415. 2.Borrego F. (2013) Blood 121:1951. 3.Vitallé J. et al. (2019) Eur J Immunol. 49(3):364.

背景介绍

CMRF-35-like molecule-6 (CLM-6), known as LMIR8, CMRF-35A1, and CD300c, is a type I transmembrane glycoprotein belonging to the immunoregulatory signaling (IRS) family of immunoglobulin-like molecules. A charged amino acid residue in the transmembrane domain of CD300c/CLM-6, found in additional family members CLM‑2, CLM-4, CLM-5, and CLM-7, enables interactions with adapter proteins. CD300c has been shown to be a FcR gamma -coupled receptor that is selectively expressed in Plasmacytoid dendritic cells (pDCs). CD300c signals might negatively regulate the activation of pDCs in response to viral infections. Additional research into CD300 receptor function during viral infections could help develop novel anti-viral therapies.